Advertisement
Screener

SAREPTA THERAPEUTICS, INC. (SRPT) Debt / Equity

SAREPTA THERAPEUTICS, INC. (SRPT) Debt / Equity

  • 2024-12-31: Debt/Equity Ratio 0.74.
  • 2024-09-30: Debt/Equity Ratio 1.08.
  • 2024-06-30: Debt/Equity Ratio 1.22.
  • 2024-03-31: Debt/Equity Ratio 1.4.

Complete source-backed debt/equity ratio history.

Available history
2010-12-31 to 2024-12-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2024-12-310.74
2024-09-301.08
2024-06-301.22
2024-03-311.4
2023-12-311.56
2022-12-314.01
2015-03-310.01
2014-12-310.01
2014-09-300.01
2014-06-300.01
2014-03-310.01
2013-12-310.01
2013-09-300.01
2013-06-300.02
2013-03-310.02
2012-12-310.01
2012-09-30-0.39
2012-06-300.08
2012-03-310.13
2011-12-310.06
2011-09-300.06
2011-06-300.05
2010-12-31-0.68

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2024-12-310.74
2023-12-311.56
2022-12-314.01
2014-12-310.01
2013-12-310.01
2012-12-310.01
2011-12-310.06
2010-12-31-0.68

Similar stocks

Stock NameCountryMarket CapPE Ratio
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Biohaven Ltd. (BHVN)United States$1.990B-3.83
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
Generate Biomedicines, Inc. (GENB)United States$2.052B
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77